Extracorporeal immunomodulation in chronic hepatitis type B with double filtration plasmapheresis.
Fujikawa
M
M
First Department of Internal Medicine, Kochi Medical School, Japan.
Tomita
A
A
Nakata
S
S
Matuura
Y
Y
Azechi
H
H
Saibara
T
T
Onishi
S
S
Yamamoto
Y
Y
D000410:Alanine Transaminase / Q000097:blood; D003131:Combined Modality Therapy; D004259:DNA-Directed DNA Polymerase / Q000097:blood; D005374:Filtration / Q000379:methods; D006509:Hepatitis B / Q000097:blood / Q000382:microbiology / Q000628:therapy*; D006513:Hepatitis B e Antigens / Q000097:blood; D006521:Hepatitis, Chronic / Q000097:blood / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D010956:Plasmapheresis / Q000379:methods*; D014779:Virus Replication
D006513:Hepatitis B e Antigens; D007370:Interferon Type I; D000410:Alanine Transaminase; D004259:DNA-Directed DNA Polymerase